At the lab there is one 1st research engineer and part-time four clinicians who are PhD students (with Lindahl as second supervisior).
We study regulation of platelet activation and interaction with coagulation- from biochemistry and genes to clinical studies on antithrombotic drugs in cardiovascular diseases and how covid-19 causes thrombosis. Furthermore, we develop new diagnostic methods.
The group has collaborations with several clinical researchers at the University Hospital in Link枚ping, Swedish biotechnology companies and university research laboratories in Sweden and Norway.
